PBMCs obtained as mentioned above from 10 healthy donors were cultured in round-bottom 96-well plates and stimulated with anti-CD3 antibody (0.5 μg/mL, BioLegend) or anti-CD3/CD28 beads (4 μL/well, Thermo Fisher Scientific). Th9 cell induction with or without anti-PD-1 antibody (2 μg/mL, 10 μg/mL, or 50 μg/mL, J105, eBioscience) or anti-PD-L1 antibody (10 μg/mL, B7H1, BioLegend) was assessed by flow cytometry after 72 h of culture with recombinant IL-4 (10 ng/mL, BioLegend), recombinant TGF-β (10 ng/mL, BioLegend), both, or neither as control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.